Needham & Company LLC Begins Coverage on Artiva Biotherapeutics (NASDAQ:ARTV)
Needham & Company LLC began coverage on shares of Artiva Biotherapeutics (NASDAQ:ARTV – Free Report) in a research note published on Tuesday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $23.00 target price on the stock. Artiva Biotherapeutics Trading Down 0.6 % Artiva Biotherapeutics stock opened at $11.36 on Tuesday. Artiva Biotherapeutics […]
More Stories
Southern Silver Exploration (CVE:SSV) Trading 5.4% Higher – Here’s Why
Southern Silver Exploration Corp. (CVE:SSV – Get Free Report)’s share price was up 5.4% on Wednesday . The company traded...
iShares Currency Hedged MSCI Italy ETF (NYSEARCA:HEWI) Stock Price Down 0.5% – What’s Next?
iShares Currency Hedged MSCI Italy ETF (NYSEARCA:HEWI – Get Free Report) traded down 0.5% during mid-day trading on Wednesday ....
Renishaw plc (OTCMKTS:RNSHF) Short Interest Update
Renishaw plc (OTCMKTS:RNSHF – Get Free Report) was the recipient of a significant drop in short interest in December. As...
iShares Transition-Enabling Metals ETF (NASDAQ:TMET) Sees Large Increase in Short Interest
iShares Transition-Enabling Metals ETF (NASDAQ:TMET – Get Free Report) was the recipient of a significant increase in short interest during...
British Smaller Companies VCT2 (LON:BSC) Shares Down 1.9% – Time to Sell?
British Smaller Companies VCT2 (LON:BSC – Get Free Report)’s share price was down 1.9% on Wednesday . The stock traded...
DiamondPeak (OTCMKTS:DPHCU) Shares Down 13.7% – Should You Sell?
DiamondPeak Holdings Corp. (OTCMKTS:DPHCU – Get Free Report)’s share price fell 13.7% during trading on Wednesday . The company traded...